Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Michael Dechant"'
Autor:
Stefanie Derer, Sven Berger, Martin Schlaeth, Tanja Schneider-Merck, Katja Klausz, Stefan Lohse, Marije B. Overdijk, Michael Dechant, Christian Kellner, Iris Nagelmeier, Andreas H. Scheel, Jeroen J. Lammerts van Bueren, Jan G.J. van de Winkel, Paul W.H.I. Parren, Matthias Peipp, Thomas Valerius
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 14, Iss 3, Pp 190-205 (2012)
Oncogenic KRAS mutations in colorectal cancer (CRC) are associated with lack of benefit from epidermal growth factor receptor (EGFR)-directed antibody (Ab) therapy. However, the mechanisms by which constitutively activated KRAS (KRASG12V) impairs eff
Externí odkaz:
https://doaj.org/article/f35805a210d2477089c2536154f9e1ad
Autor:
Thomas Valerius, Jan G.J. van de Winkel, Paul W.H.I. Parren, Wim K. Bleeker, Jeroen J. Lammerts van Bueren, Tanja Schneider-Merck, Thomas Beyer, Matthias Peipp, Sven Berger, Wencke Weisner, Michael Dechant
Supplementary Table 1 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b76607673903b3ff12168cd2c6a3316
https://doi.org/10.1158/0008-5472.22375119
https://doi.org/10.1158/0008-5472.22375119
Autor:
Thomas Valerius, Jan G.J. van de Winkel, Paul W.H.I. Parren, Wim K. Bleeker, Jeroen J. Lammerts van Bueren, Tanja Schneider-Merck, Thomas Beyer, Matthias Peipp, Sven Berger, Wencke Weisner, Michael Dechant
Supplementary Figure 4 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa18735be8bf20a0a67187efffc73d5
https://doi.org/10.1158/0008-5472.22375131
https://doi.org/10.1158/0008-5472.22375131
Autor:
Thomas Valerius, Jan G.J. van de Winkel, Paul W.H.I. Parren, Wim K. Bleeker, Jeroen J. Lammerts van Bueren, Tanja Schneider-Merck, Thomas Beyer, Matthias Peipp, Sven Berger, Wencke Weisner, Michael Dechant
Supplementary Figure 1 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30903a26acdd86dd89717598b77e8507
https://doi.org/10.1158/0008-5472.22375143.v1
https://doi.org/10.1158/0008-5472.22375143.v1
Autor:
Thomas Valerius, Jan G.J. van de Winkel, Paul W.H.I. Parren, Wim K. Bleeker, Jeroen J. Lammerts van Bueren, Tanja Schneider-Merck, Thomas Beyer, Matthias Peipp, Sven Berger, Wencke Weisner, Michael Dechant
Supplementary Figure 5 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab88ba44e3be204e7ce142a986edea7
https://doi.org/10.1158/0008-5472.22375128.v1
https://doi.org/10.1158/0008-5472.22375128.v1
Autor:
Thomas Valerius, Jan G.J. van de Winkel, Paul W.H.I. Parren, Wim K. Bleeker, Jeroen J. Lammerts van Bueren, Tanja Schneider-Merck, Thomas Beyer, Matthias Peipp, Sven Berger, Wencke Weisner, Michael Dechant
Supplementary Legends of Tables 1-2, Figures 1-5 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aedcbec2441ae30a27e2b955ccc2bb14
https://doi.org/10.1158/0008-5472.22375125
https://doi.org/10.1158/0008-5472.22375125
Autor:
Thomas Valerius, Jan G.J. van de Winkel, Paul W.H.I. Parren, Wim K. Bleeker, Jeroen J. Lammerts van Bueren, Tanja Schneider-Merck, Thomas Beyer, Matthias Peipp, Sven Berger, Wencke Weisner, Michael Dechant
Supplementary Figure 3 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62d338a58299ddd470a14f37659d4877
https://doi.org/10.1158/0008-5472.22375134
https://doi.org/10.1158/0008-5472.22375134
Autor:
Thomas Valerius, Jan G.J. van de Winkel, Paul W.H.I. Parren, Wim K. Bleeker, Jeroen J. Lammerts van Bueren, Tanja Schneider-Merck, Thomas Beyer, Matthias Peipp, Sven Berger, Wencke Weisner, Michael Dechant
Therapeutic monoclonal antibodies against the epidermal growth factor receptor (EGFR) have advanced the treatment of colon and head and neck cancer, and show great promise for the development of treatments for other solid cancers. Antibodies against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567381f7c758e05acc72db0d0c60ea43
https://doi.org/10.1158/0008-5472.c.6497718.v1
https://doi.org/10.1158/0008-5472.c.6497718.v1
Autor:
Thomas Valerius, Jan G.J. van de Winkel, Paul W.H.I. Parren, Wim K. Bleeker, Jeroen J. Lammerts van Bueren, Tanja Schneider-Merck, Thomas Beyer, Matthias Peipp, Sven Berger, Wencke Weisner, Michael Dechant
Supplementary Table 2 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc444dd9079e7ce361ba7def33d64876
https://doi.org/10.1158/0008-5472.22375116.v1
https://doi.org/10.1158/0008-5472.22375116.v1
Autor:
Thomas Valerius, Jan G.J. van de Winkel, Paul W.H.I. Parren, Wim K. Bleeker, Jeroen J. Lammerts van Bueren, Tanja Schneider-Merck, Thomas Beyer, Matthias Peipp, Sven Berger, Wencke Weisner, Michael Dechant
Supplementary Figure 2 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0287ddb5bd3176524886692a180fb99f
https://doi.org/10.1158/0008-5472.22375140.v1
https://doi.org/10.1158/0008-5472.22375140.v1